OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Advances in pharmacotherapy for advanced thyroid cancer of follicular origin (PTC, FTC). New approved drugs and future therapies
Giusy Elia, Silvia Martina Ferrari, Francesca Ragusa, et al.
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 5, pp. 599-610
Closed Access | Times Cited: 9
Giusy Elia, Silvia Martina Ferrari, Francesca Ragusa, et al.
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 5, pp. 599-610
Closed Access | Times Cited: 9
Showing 9 citing articles:
Molecular features of aggressive thyroid cancer
Giusy Elia, Armando Patrizio, Francesca Ragusa, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 23
Giusy Elia, Armando Patrizio, Francesca Ragusa, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 23
TP53 Alterations Associate with Poor Response to Lenvatinib in Patients with Advanced Thyroid Cancer
Valentina Cirello, Carla Colombo, Delfina Tosi, et al.
The Journal of Clinical Endocrinology & Metabolism (2025)
Open Access
Valentina Cirello, Carla Colombo, Delfina Tosi, et al.
The Journal of Clinical Endocrinology & Metabolism (2025)
Open Access
Advanced Differentiated Thyroid Cancer: A Complex Condition Needing a Tailored Approach
Antonio Mario Bulfamante, Eleonora Lori, Maria Irene Bellini, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 18
Antonio Mario Bulfamante, Eleonora Lori, Maria Irene Bellini, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 18
Anti-EGFR/BRAF-Tyrosine Kinase Inhibitors in Thyroid Carcinoma
Vasileios Papanikolaou, Efthymios Kyrodimos, Nicholas Mastronikolis, et al.
Cancer Diagnosis & Prognosis (2023) Vol. 3, Iss. 2, pp. 151-156
Open Access | Times Cited: 5
Vasileios Papanikolaou, Efthymios Kyrodimos, Nicholas Mastronikolis, et al.
Cancer Diagnosis & Prognosis (2023) Vol. 3, Iss. 2, pp. 151-156
Open Access | Times Cited: 5
Transcriptome Profiling of Adolescents and Young Adults Papillary Thyroid Carcinoma: Unveiling Developmental Differences in Lymph Node Metastasis
wangbo fjmu.edu.cn WANG, Wei Ao, Si-Si wang, et al.
Research Square (Research Square) (2024)
Open Access
wangbo fjmu.edu.cn WANG, Wei Ao, Si-Si wang, et al.
Research Square (Research Square) (2024)
Open Access
NF-κB Mediated Thyroid Inflammation and Its Implications for the Risk of Follicular Thyroid Carcinoma: a systematic review
Ovais Shafi, Raveena, Fatima Arshad, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Ovais Shafi, Raveena, Fatima Arshad, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Antineoplastic effect of doxorubizen in vitro in continuous and primary human anaplastic thyroid cancer cells
Giusy Elia, Silvia Martina Ferrari, Iryna Tkachenko, et al.
Endocrine (2024)
Closed Access
Giusy Elia, Silvia Martina Ferrari, Iryna Tkachenko, et al.
Endocrine (2024)
Closed Access
Editorial: Differential diagnoses of thyroid neoplasms: Molecular and histological features and the impact on follow-up
Salvatore Sorrenti, Augusto Lauro, Daniele Pironi, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access
Salvatore Sorrenti, Augusto Lauro, Daniele Pironi, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access
